This information is intended for healthcare professionals based in Belgium and Luxembourg.
If you are not a healthcare professional, click here

Opdivo_Yervoy_Logo Opdivo_Yervoy_Logo Opdivo_Logo Opdivo_Chemotherapy_Logo

Advanced Melanoma

THE FIRST AND ONLY DUAL IMMUNOTHERAPY IN ADVANCED MELANOMA

View indication details

  • OPDIVO as monotherapy or in combination with ipilimumab is indicated for the treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older.
Expert opinion

NEW

Optimal treatment
sequence in BRAF-mutated
adv. melanoma

A library of patient
cases
treated with
OPDIVO+YERVOY
in advanced melanoma

Product information

A short video on
the rationale of combining
OPDIVO and YERVOY
in collaboration with
P. Coulie

Practical user guide
based on OPDIVO SmPC

Dosing scheme
OPDIVO+YERVOY
in advanced melanoma

Patient & nurse materials

Patient support program
OPDIVO + YERVOY

A diary for your patients
treated with OPDIVO + YERVOY

www.immunooncology.be

An educational website
on immunotherapy
for your nurses

For more patient & nurse materials
click here

irAE(s), immune-related adverse event(s)